Current Location:School > Home > Deparment of Pharmacy Administration and Clinical Pharmacy

Guan Xiaodong

    

  

Associate Professor Xiaodong Guan, PhD

Department of Pharmacy Administration and Clinical Pharmacy,

School of Pharmaceutical Sciences, Peking University, Beijing 100191, China

Tel : +8610 8280 5019  Email: guanxiaodong@bjmu.edu.cn

 

Research Areas

Pharmaceutical Policy; Drug Access and Equity; Drug inappropriate Use; Drug Utilization.

Education

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutics Sciences, Peking University Health Science Center, M.S. in 2008 and Ph.D., 2011

School of Pharmaceutics Sciences, Peking University Health Science Center, B.S., 2004

Positions

  Associate Professor, Deputy Dean, Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutics Sciences, Peking University Health Science Center, 2018-

Visiting Scholar,Harvard Medical School, USA,2018-19

Senior Researcher, International Research Centre for Medicinal Administration (IRCMA), Peking University, 2011-

Assistant Professor, Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutics Sciences, Peking University Health Science Center, 2011-18

Faculty Accolades

  Excellent Teaching Award (Post Graduate), Peking University Health Science Center, 2017-18, 2014-15, 2012-13

  Excellent Teaching Award, Peking University Health Science Center, 2016-17

  Outstanding Youth Post Expert, Peking University, 2016-17

  Outstanding Communist and Pacemaker to Excellent Class Teacher, Peking University, 2015-16

  Excellent Class Headmaster, Peking University, 2013-14

Research Interests

  Our research team spans a broad range of pharmaceutical policies. We study appropriate medicine use and access to medicines, tried to provide evidence and push forward related policies to promote drug rational use and accessibility of drugs. We are also committed to studying the effectiveness and improvement measures of essential medicines policy.

Grants and funding

  Research on the Evaluation and Optimization of the Full coverage Policy of Essential Medicine: Based on the Theory of Cross-subsidy. Funded by National Natural Science Foundation of China No.71774005, Principal Investigator

  Research on the evaluation of the effect of NEMP in China. Funded by National Natural Science Foundation of China,No.71303011, Principal Investigator

  Evaluation on Medication Rational use in Primary Healthcare Institutions in Dongcheng District of Beijing. Funded by HFPC of Dongcheng District of Beijing, Principal Investigator

  Analysis of quantity based pricing by centralized bidding procurement of essential medicines. Funded by NHFPC, Principal Investigator

Publications

Xiaodong Guan, Jingyuan Zhang, Chunxia Man, Bingyu Ni, Luwen Shi#. How far have we come? challenges to orphan drugs access in China, 2011-2017.Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2019.01.012

Xiaodong Guan, Ye Tian, Jiafang Song, Dawei Zhu, Luwen Shi#. Effect of physicians' knowledge on antibiotics rational use in China's county hospitals. Social Science &Medicine. https://doi.org/10.1016/j.socscimed.2019.01.049

Guan X, Hu H, Man C, Shi L#. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals. International Journal for equity in health. 2018 Oct 19;17(1):158. doi: 10.1186/s12939-018-0870-5.

Guan X, Tian Y, Ross-Degnan D, Man C, Shi L#. Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China. BMJ Open. 2018 Jul 16;8(7):e022328.

  Xiaodong Guan, Mingchun Yang, Chunxia Man, Ye Tian, Luwen Shi#.The effect of the implementation of low price medicine policy on medicine price in China: A retrospective study. International Journal of Health Planning and Management. 2018 Apr 30. doi: 10.1002/hpm.2537.

  Xiaodong Guan, Lili Ma, Haishaerjiang Wushouer, Chunxia Man, Sheng Han, Luwen Shi*.Determinants of self-monitoring of blood glucose with type 2 diabetes based on 496 questionnaire surveys in China. International Journal of Diabetes in Developing Countries.2018 April 04. https://doi.org/10.1007/s13410-018-0627-0

  Zhigang Guo, Xiaodong Guan#, and Luwen Shi. The impacts of the implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China. BMC Health Service Research. 2017 Nov 13;17(1):723.

  Xiaodong Guan, Huigang Liang, Yajiong Xue, Luwen Shi#. An analysis of China's national essential medicines policy. Journal of Public Health Policy. Aug2011, Vol. 32 Issue 3, p305-319. 15p. 3 Charts.

  Dong P, Hu H, Guan X, Ung CO, Shi L, Han S#, Yu S#. Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease. Chinese Medicine. 2018;13(1):28

Wushouer H, Tian Y, Guan XD, Han S, Shi LW#. Trends and patterns of antibiotic consumption in China's tertiary hospitals: Based on a 5-year surveillance with sales records, 2011-2015. PLoS One. 2017 Dec 27;12(12):e0190314.